S&P 500   4,282.37 (+1.45%)
DOW   33,762.76 (+2.12%)
QQQ   354.65 (+0.75%)
AAPL   180.95 (+0.48%)
MSFT   335.40 (+0.85%)
META   272.61 (+0.00%)
GOOGL   124.67 (+0.77%)
AMZN   124.25 (+1.21%)
TSLA   213.97 (+3.11%)
NVDA   393.27 (-1.11%)
NIO   7.56 (+0.27%)
BABA   84.26 (+1.52%)
AMD   117.86 (-1.35%)
T   15.21 (-3.86%)
F   12.38 (+2.23%)
MU   69.17 (+0.12%)
CGC   0.83 (-1.20%)
GE   105.79 (+1.07%)
DIS   90.77 (+2.46%)
AMC   4.56 (+0.00%)
PFE   38.35 (+0.87%)
PYPL   63.96 (+1.44%)
NFLX   400.47 (-0.66%)
S&P 500   4,282.37 (+1.45%)
DOW   33,762.76 (+2.12%)
QQQ   354.65 (+0.75%)
AAPL   180.95 (+0.48%)
MSFT   335.40 (+0.85%)
META   272.61 (+0.00%)
GOOGL   124.67 (+0.77%)
AMZN   124.25 (+1.21%)
TSLA   213.97 (+3.11%)
NVDA   393.27 (-1.11%)
NIO   7.56 (+0.27%)
BABA   84.26 (+1.52%)
AMD   117.86 (-1.35%)
T   15.21 (-3.86%)
F   12.38 (+2.23%)
MU   69.17 (+0.12%)
CGC   0.83 (-1.20%)
GE   105.79 (+1.07%)
DIS   90.77 (+2.46%)
AMC   4.56 (+0.00%)
PFE   38.35 (+0.87%)
PYPL   63.96 (+1.44%)
NFLX   400.47 (-0.66%)
S&P 500   4,282.37 (+1.45%)
DOW   33,762.76 (+2.12%)
QQQ   354.65 (+0.75%)
AAPL   180.95 (+0.48%)
MSFT   335.40 (+0.85%)
META   272.61 (+0.00%)
GOOGL   124.67 (+0.77%)
AMZN   124.25 (+1.21%)
TSLA   213.97 (+3.11%)
NVDA   393.27 (-1.11%)
NIO   7.56 (+0.27%)
BABA   84.26 (+1.52%)
AMD   117.86 (-1.35%)
T   15.21 (-3.86%)
F   12.38 (+2.23%)
MU   69.17 (+0.12%)
CGC   0.83 (-1.20%)
GE   105.79 (+1.07%)
DIS   90.77 (+2.46%)
AMC   4.56 (+0.00%)
PFE   38.35 (+0.87%)
PYPL   63.96 (+1.44%)
NFLX   400.47 (-0.66%)
S&P 500   4,282.37 (+1.45%)
DOW   33,762.76 (+2.12%)
QQQ   354.65 (+0.75%)
AAPL   180.95 (+0.48%)
MSFT   335.40 (+0.85%)
META   272.61 (+0.00%)
GOOGL   124.67 (+0.77%)
AMZN   124.25 (+1.21%)
TSLA   213.97 (+3.11%)
NVDA   393.27 (-1.11%)
NIO   7.56 (+0.27%)
BABA   84.26 (+1.52%)
AMD   117.86 (-1.35%)
T   15.21 (-3.86%)
F   12.38 (+2.23%)
MU   69.17 (+0.12%)
CGC   0.83 (-1.20%)
GE   105.79 (+1.07%)
DIS   90.77 (+2.46%)
AMC   4.56 (+0.00%)
PFE   38.35 (+0.87%)
PYPL   63.96 (+1.44%)
NFLX   400.47 (-0.66%)
NYSEAMERICAN:ARMP

Armata Pharmaceuticals (ARMP) Stock Forecast, Price & News

$1.61
+0.11 (+7.33%)
(As of 06/2/2023 ET)
Compare
Today's Range
$1.46
$1.70
50-Day Range
N/A
52-Week Range
$0.83
$4.92
Volume
47,142 shs
Average Volume
14,270 shs
Market Capitalization
$58.20 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$7.00

Armata Pharmaceuticals MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
334.8% Upside
$7.00 Price Target
Short Interest
Healthy
0.20% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($1.32) to ($0.35) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.34 out of 5 stars


ARMP stock logo

About Armata Pharmaceuticals (NYSEAMERICAN:ARMP) Stock

Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, which focuses on the development of bacteriophage therapeutics for the treatment of drug-resistant bacterial infections. The company was founded on May 9, 2019 and is headquartered in Los Angeles, CA.

Receive ARMP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Armata Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

ARMP Stock News Headlines

“Amazon Loophole” could hand you $28,544 in “royalty” payouts
Thanks to a little-known IRS loophole… Regular Americans can collect up to $28,544 (or more) in payouts from what Brad Thomas calls the “Amazon secret royalty program…” See how to collect the next payout before the strict cutoff deadline.
“Amazon Loophole” could hand you $28,544 in “royalty” payouts
Thanks to a little-known IRS loophole… Regular Americans can collect up to $28,544 (or more) in payouts from what Brad Thomas calls the “Amazon secret royalty program…” See how to collect the next payout before the strict cutoff deadline.
Armata Pharmaceuticals, Inc. (ARMP)
See More Headlines

ARMP Price History

ARMP Company Calendar

Last Earnings
3/16/2023
Today
6/02/2023
Next Earnings (Estimated)
8/09/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Biological products, except diagnostic
Sub-Industry
N/A
Sector
Medical
Current Symbol
NYSEAMERICAN:ARMP
CIK
N/A
Employees
69
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$7.00
High Stock Price Forecast
$7.00
Low Stock Price Forecast
$7.00
Forecasted Upside/Downside
+340.3%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$-36,920,000.00
Net Margins
-841.24%
Pretax Margin
-841.22%

Debt

Sales & Book Value

Annual Sales
$5.51 million
Book Value
$0.62 per share

Miscellaneous

Free Float
7,193,000
Market Cap
$57.48 million
Optionable
Not Optionable
Beta
1.17

Key Executives

  • Brian C. Varnum
    Chief Executive Officer & Director
  • Duane A. Morris
    Vice President-Operations
  • Julianne Averill
    Chief Financial & Accounting Officer
  • Mina Pastagia
    Chief Medical Officer
  • Bryan Kadotani
    Vice President-Program Management & Operations













ARMP Stock - Frequently Asked Questions

Should I buy or sell Armata Pharmaceuticals stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Armata Pharmaceuticals in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" ARMP shares.
View ARMP analyst ratings
or view top-rated stocks.

What is Armata Pharmaceuticals' stock price forecast for 2023?

1 brokerages have issued 1 year price objectives for Armata Pharmaceuticals' shares. Their ARMP share price forecasts range from $7.00 to $7.00. On average, they anticipate the company's share price to reach $7.00 in the next twelve months. This suggests a possible upside of 340.3% from the stock's current price.
View analysts price targets for ARMP
or view top-rated stocks among Wall Street analysts.

Are investors shorting Armata Pharmaceuticals?

Armata Pharmaceuticals saw a decline in short interest in May. As of May 15th, there was short interest totaling 21,900 shares, a decline of 41.8% from the April 30th total of 37,600 shares. Based on an average trading volume of 12,900 shares, the days-to-cover ratio is presently 1.7 days. Currently, 0.2% of the company's shares are short sold.
View Armata Pharmaceuticals' Short Interest
.

When is Armata Pharmaceuticals' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, August 9th 2023.
View our ARMP earnings forecast
.

How were Armata Pharmaceuticals' earnings last quarter?

Armata Pharmaceuticals, Inc. (NYSEAMERICAN:ARMP) announced its quarterly earnings data on Thursday, March, 16th. The company reported ($0.29) earnings per share for the quarter, missing the consensus estimate of ($0.25) by $0.04. The company earned $1.05 million during the quarter, compared to analysts' expectations of $1.34 million. Armata Pharmaceuticals had a negative net margin of 841.24% and a negative trailing twelve-month return on equity of 108.35%.

What other stocks do shareholders of Armata Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Armata Pharmaceuticals investors own include VBI Vaccines (VBIV), Vaxart (VXRT), Amarin (AMRN), CRISPR Therapeutics (CRSP), Pfizer (PFE), Micron Technology (MU), Aduro Biotech (ADRO), Occidental Petroleum (OXY) and Gilead Sciences (GILD).

What is Armata Pharmaceuticals' stock symbol?

Armata Pharmaceuticals trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "ARMP."

Who are Armata Pharmaceuticals' major shareholders?

Armata Pharmaceuticals' stock is owned by a variety of retail and institutional investors. Top institutional investors include Renaissance Technologies LLC (0.17%), HRT Financial LP (0.09%) and Simplex Trading LLC (0.00%).
View institutional ownership trends
.

How do I buy shares of Armata Pharmaceuticals?

Shares of ARMP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Armata Pharmaceuticals' stock price today?

One share of ARMP stock can currently be purchased for approximately $1.59.

How much money does Armata Pharmaceuticals make?

Armata Pharmaceuticals (NYSEAMERICAN:ARMP) has a market capitalization of $57.48 million and generates $5.51 million in revenue each year. The company earns $-36,920,000.00 in net income (profit) each year or ($1.19) on an earnings per share basis.

How can I contact Armata Pharmaceuticals?

Armata Pharmaceuticals' mailing address is 4503 GLENCOE AVENUE, MARINA DEL REY CA, 90292. The official website for the company is www.armatapharma.com. The company can be reached via phone at (310) 655-2928, via email at jallaire@lifesciadvisors.com, or via fax at 310-665-2963.

This page (NYSEAMERICAN:ARMP) was last updated on 6/2/2023 by MarketBeat.com Staff

My Account -